The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

S.M. Böger

Institute of Clinical Pharmacology

Hannover Medical School

Germany

[email]@mh-hannover.de

Name/email consistency: high

[Claim this account]

Affiliation

Institute of Clinical Pharmacology, Hannover Medical School, Germany. 1998 - 2000

References

Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis. Bode-Böger, S.M., Böger, R.H., Kielstein, J.T., Löffler, M., Schäffer, J., Frölich, J.C. J. Investig. Med. (2000) [Pubmed]
Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Böger, R.H., Bode-Böger, S.M., Sydow, K., Heistad, D.D., Lentz, S.R. Arterioscler. Thromb. Vasc. Biol. (2000) [Pubmed]
LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Böger, R.H., Sydow, K., Borlak, J., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., Bode-Böger, S.M. Circ. Res. (2000) [Pubmed]
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Böger, R.H., Bode-Böger, S.M. Semin. Thromb. Hemost. (2000) [Pubmed]
Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans. Böger, R.H. J. Endocrinol. Invest. (1999) [Pubmed]
Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. Böger, R.H., Bode-Böger, S.M., Thiele, W., Creutzig, A., Alexander, K., Frölich, J.C. J. Am. Coll. Cardiol. (1998) [Pubmed]